The agency’s obsession with adolescent vaping is driving decisions that undermine public health.
The Food and Drug Administration (FDA) recently issued “marketing denial orders” (MDOs) for the myblu vaping device and several of its tobacco-flavored proprietary pods.
The decision, which the FDA announced last Friday, affects one of the leading e-cigarette brands and does not bode well for smokers who have switched to vaping or might be interested in doing so.
The FDA concluded that allowing the sale of the myblu products would not be “appropriate for the protection of the public health,” which illustrates how nebulous that standard is and how arbitrarily the FDA applies it.
Jacob Sullum – Reason – 2022-04-13
Want More Investigative Content?
